{"count": 23, "results": [{"_id": "32974359", "pmid": 32974359, "pmcid": "PMC7466644", "title": "Metformin in Pulmonary Hypertension in Left Heart Disease", "journal": "Front Med (Lausanne)", "authors": ["Mulkareddy V", "Simon MA"], "date": "2020-08-19T00:00:00Z", "doi": "10.3389/fmed.2020.00425", "meta_date_publication": "2020", "meta_volume": "7", "meta_issue": "", "meta_pages": "425", "score": 50270.4, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@Pulmonary Hypertension@@@ in @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@Left Heart Disease@@@", "citations": {"NLM": "Mulkareddy V, Simon MA. Metformin in Pulmonary Hypertension in Left Heart Disease Front Med (Lausanne). 2020;7():425. PMID: 32974359", "BibTeX": "@article{32974359, title={Metformin in Pulmonary Hypertension in Left Heart Disease}, author={Mulkareddy V and Simon MA}, journal={Front Med (Lausanne)}, volume={7}, pages={425}}"}}, {"_id": "36120288", "pmid": 36120288, "pmcid": "PMC9479636", "title": "Effects of the peripheral CB1 receptor antagonist JD5037 in mono: and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension", "journal": "Front Pharmacol", "authors": ["Remiszewski P", "Pędzińska-Betiuk A", "Mińczuk K", "Schlicker E", "Klimek J", "Dzięcioł J", "Malinowska B"], "date": "2022-09-02T00:00:00Z", "doi": "10.3389/fphar.2022.965613", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "965613", "score": 50268.832, "text_hl": "There were 8 groups of animals: 1) CTR + veh, 2) CTR + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@, 3) CTR + JD, 4) CTR + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ + JD, 5) @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@PH@@@ + veh, 6) @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@PH@@@ + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@, 7) @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@PH@@@ + JD and 8) @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@PH@@@ + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ + JD. ", "citations": {"NLM": "Remiszewski P, Pędzińska-Betiuk A, Mińczuk K, Schlicker E, Klimek J, Dzięcioł J, Malinowska B. Effects of the peripheral CB1 receptor antagonist JD5037 in mono: and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension Front Pharmacol. 2022;13():965613. PMID: 36120288", "BibTeX": "@article{36120288, title={Effects of the peripheral CB1 receptor antagonist JD5037 in mono: and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension}, author={Remiszewski P and Pędzińska-Betiuk A and Mińczuk K and Schlicker E and Klimek J and Dzięcioł J and Malinowska B}, journal={Front Pharmacol}, volume={13}, pages={965613}}"}}, {"_id": "34169079", "pmid": 34169079, "pmcid": "PMC8217619", "title": "AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling", "journal": "Front Cell Dev Biol", "authors": ["Zhao Q", "Song P", "Zou MH"], "date": "2021-06-08T00:00:00Z", "doi": "10.3389/fcell.2021.691585", "meta_date_publication": "2021", "meta_volume": "9", "meta_issue": "", "meta_pages": "691585", "score": 50261.707, "text_hl": "Thus, a sex difference might affect the response to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment of @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@PH@@@. ", "citations": {"NLM": "Zhao Q, Song P, Zou MH. AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling Front Cell Dev Biol. 2021;9():691585. PMID: 34169079", "BibTeX": "@article{34169079, title={AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling}, author={Zhao Q and Song P and Zou MH}, journal={Front Cell Dev Biol}, volume={9}, pages={691585}}"}}, {"_id": "33093887", "pmid": 33093887, "pmcid": "PMC7571338", "title": "Metformin prevents the development of monocrotaline-induced pulmonary hypertension by decreasing serum levels of big endothelin-1", "journal": "Exp Ther Med", "authors": ["Yoshida T", "Matsuura K", "Goya S", "Ma D", "Shimada K", "Kitpipatkun P", "Namiki R", "Uemura A", "Suzuki K", "Tanaka R"], "date": "2020-12-01T00:00:00Z", "doi": "10.3892/etm.2020.9278", "meta_date_publication": "2020 Dec", "meta_volume": "20", "meta_issue": "6", "meta_pages": "149", "score": 50258.22, "text_hl": "Thus, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may represent a novel therapeutic agent for @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@PH@@@. ", "citations": {"NLM": "Yoshida T, Matsuura K, Goya S, Ma D, Shimada K, Kitpipatkun P, Namiki R, Uemura A, Suzuki K, Tanaka R. Metformin prevents the development of monocrotaline-induced pulmonary hypertension by decreasing serum levels of big endothelin-1 Exp Ther Med. 2020 Dec;20(6):149. PMID: 33093887", "BibTeX": "@article{33093887, title={Metformin prevents the development of monocrotaline-induced pulmonary hypertension by decreasing serum levels of big endothelin-1}, author={Yoshida T and Matsuura K and Goya S and Ma D and Shimada K and Kitpipatkun P and Namiki R and Uemura A and Suzuki K and Tanaka R}, journal={Exp Ther Med}, volume={20}, number={6}, pages={149}}"}}, {"_id": "36914083", "pmid": 36914083, "title": "AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery.", "journal": "Eur J Pharmacol", "authors": ["Abdelazeem H", "Tu L", "Thuillet R", "Ottaviani M", "Boulfrad A", "Beck T", "Senbel A", "Mani S", "Castier Y", "Guyard A", "Tran-Dinh A", "El-Benna J", "Longrois D", "Silverstein AM", "Guignabert C", "Norel X"], "date": "2023-05-05T00:00:00Z", "doi": "10.1016/j.ejphar.2023.175579", "meta_date_publication": "2023 May 5", "meta_volume": "946", "meta_issue": "", "meta_pages": "175579", "score": 50257.156, "text_hl": "@GENE_PRKAA2 @GENE_78975 @@@AMPK@@@ activation by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protects against @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@pulmonary hypertension@@@ in @SPECIES_10116 @@@rats@@@ and relaxes isolated @SPECIES_9606 @@@human@@@ pulmonary artery.", "citations": {"NLM": "Abdelazeem H, Tu L, Thuillet R, Ottaviani M, Boulfrad A, Beck T, Senbel A, Mani S, Castier Y, Guyard A, Tran-Dinh A, El-Benna J, Longrois D, Silverstein AM, Guignabert C, Norel X. AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery. Eur J Pharmacol. 2023 May 5;946():175579. PMID: 36914083", "BibTeX": "@article{36914083, title={AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery.}, author={Abdelazeem H and Tu L and Thuillet R and Ottaviani M and Boulfrad A and Beck T and Senbel A and Mani S and Castier Y and Guyard A and Tran-Dinh A and El-Benna J and Longrois D and Silverstein AM and Guignabert C and Norel X}, journal={Eur J Pharmacol}, volume={946}, pages={175579}}"}}, {"_id": "37389952", "pmid": 37389952, "title": "Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.", "journal": "Am J Physiol Heart Circ Physiol", "authors": ["McNair BD", "Polson SM", "Shorthill SK", "Yusifov A", "Walker LA", "Weiser-Evans MCM", "Kovacs EJ", "Bruns DR"], "date": "2023-06-30T00:00:00Z", "doi": "10.1152/ajpheart.00124.2023", "meta_date_publication": "2023 Jun 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.375, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ protects against @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@pulmonary hypertension@@@-induced @DISEASE_Ventricular_Dysfunction_Right @DISEASE_MESH:D018497 @@@right ventricular dysfunction@@@ in an age- and sex-specific manner independent of cardiac AMPK.", "citations": {"NLM": "McNair BD, Polson SM, Shorthill SK, Yusifov A, Walker LA, Weiser-Evans MCM, Kovacs EJ, Bruns DR. Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK. Am J Physiol Heart Circ Physiol. 2023 Jun 30;():. PMID: 37389952", "BibTeX": "@article{37389952, title={Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.}, author={McNair BD and Polson SM and Shorthill SK and Yusifov A and Walker LA and Weiser-Evans MCM and Kovacs EJ and Bruns DR}, journal={Am J Physiol Heart Circ Physiol}}"}}, {"_id": "32268788", "pmid": 32268788, "title": "Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.", "journal": "Arterioscler Thromb Vasc Biol", "authors": ["Wang L", "Halliday G", "Huot JR", "Satoh T", "Baust JJ", "Fisher A", "Cook T", "Hu J", "Avolio T", "Goncharov DA", "Bai Y", "Vanderpool RR", "Considine RV", "Bonetto A", "Tan J", "Bachman TN", "Sebastiani A", "McTiernan CF", "Mora AL", "Machado RF", "Goncharova EA", "Gladwin MT", "Lai YC"], "date": "2020-06-01T00:00:00Z", "doi": "10.1161/ATVBAHA.119.313883", "meta_date_publication": "2020 Jun", "meta_volume": "40", "meta_issue": "6", "meta_pages": "1543-1558", "score": 50251.215, "text_hl": "Treatment With @CHEMICAL_treprostinil @CHEMICAL_MESH:C427248 @@@Treprostinil@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Normalizes @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@Hyperglycemia@@@ and Improves Cardiac Function in @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@Pulmonary Hypertension@@@ Associated With @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@Heart Failure@@@ With Preserved Ejection Fraction.", "citations": {"NLM": "Wang L, Halliday G, Huot JR, Satoh T, Baust JJ, Fisher A, Cook T, Hu J, Avolio T, Goncharov DA, Bai Y, Vanderpool RR, Considine RV, Bonetto A, Tan J, Bachman TN, Sebastiani A, McTiernan CF, Mora AL, Machado RF, Goncharova EA, Gladwin MT, Lai YC. Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):1543-1558. PMID: 32268788", "BibTeX": "@article{32268788, title={Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.}, author={Wang L and Halliday G and Huot JR and Satoh T and Baust JJ and Fisher A and Cook T and Hu J and Avolio T and Goncharov DA and Bai Y and Vanderpool RR and Considine RV and Bonetto A and Tan J and Bachman TN and Sebastiani A and McTiernan CF and Mora AL and Machado RF and Goncharova EA and Gladwin MT and Lai YC}, journal={Arterioscler Thromb Vasc Biol}, volume={40}, number={6}, pages={1543-1558}}"}}, {"_id": "33200330", "pmid": 33200330, "pmcid": "PMC7669792", "title": "Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers", "journal": "AAPS J", "authors": ["Acosta MF", "Abrahamson MD", "Encinas-Basurto D", "Fineman JR", "Black SM", "Mansour HM"], "date": "2020-11-16T00:00:00Z", "doi": "10.1208/s12248-020-00531-3", "meta_date_publication": "2020 Nov 16", "meta_volume": "23", "meta_issue": "1", "meta_pages": "2", "score": 50250.93, "text_hl": "Since mitochondrial @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ oxidation is inhibited in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@pulmonary hypertension@@@ (@<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@PH@@@) and @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ levels are increased in endothelial and smooth muscle cells, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has been reported to have positive effects in the treatment of @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@PH@@@. ", "citations": {"NLM": "Acosta MF, Abrahamson MD, Encinas-Basurto D, Fineman JR, Black SM, Mansour HM. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers AAPS J. 2020 Nov 16;23(1):2. PMID: 33200330", "BibTeX": "@article{33200330, title={Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers}, author={Acosta MF and Abrahamson MD and Encinas-Basurto D and Fineman JR and Black SM and Mansour HM}, journal={AAPS J}, volume={23}, number={1}, pages={2}}"}}, {"_id": "32966132", "pmid": 32966132, "title": "Letter by Komamura Regarding Article, \"Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction\".", "journal": "Arterioscler Thromb Vasc Biol", "authors": ["Komamura K"], "date": "2020-10-01T00:00:00Z", "doi": "10.1161/ATVBAHA.120.314987", "meta_date_publication": "2020 Oct", "meta_volume": "40", "meta_issue": "10", "meta_pages": "e273", "score": 50246.08, "text_hl": "Letter by Komamura Regarding Article, \"Treatment With @CHEMICAL_treprostinil @CHEMICAL_MESH:C427248 @@@Treprostinil@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Normalizes @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@Hyperglycemia@@@ and Improves Cardiac Function in @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@Pulmonary Hypertension@@@ Associated With @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@Heart Failure@@@ With Preserved Ejection Fraction\".", "citations": {"NLM": "Komamura K. Letter by Komamura Regarding Article, \"Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction\". Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):e273. PMID: 32966132", "BibTeX": "@article{32966132, title={Letter by Komamura Regarding Article, \"Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction\".}, author={Komamura K}, journal={Arterioscler Thromb Vasc Biol}, volume={40}, number={10}, pages={e273}}"}}, {"_id": "32845776", "pmid": 32845776, "title": "Letter by Wang et al Regarding Article, \"Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction\".", "journal": "Arterioscler Thromb Vasc Biol", "authors": ["Wang D", "Mao Y", "Wang T", "Xiong T", "Yang X"], "date": "2020-09-01T00:00:00Z", "doi": "10.1161/ATVBAHA.120.314939", "meta_date_publication": "2020 Sep", "meta_volume": "40", "meta_issue": "9", "meta_pages": "e260-e261", "score": 50245.96, "text_hl": "Letter by Wang et al Regarding Article, \"Treatment With @CHEMICAL_treprostinil @CHEMICAL_MESH:C427248 @@@Treprostinil@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Normalizes @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@Hyperglycemia@@@ and Improves Cardiac Function in @<m>DISEASE_Hypertension_Pulmonary</m> @DISEASE_MESH:D006976 @@@Pulmonary Hypertension@@@ Associated With @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@Heart Failure@@@ With Preserved Ejection Fraction\".", "citations": {"NLM": "Wang D, Mao Y, Wang T, Xiong T, Yang X. Letter by Wang et al Regarding Article, \"Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction\". Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):e260-e261. PMID: 32845776", "BibTeX": "@article{32845776, title={Letter by Wang et al Regarding Article, \"Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction\".}, author={Wang D and Mao Y and Wang T and Xiong T and Yang X}, journal={Arterioscler Thromb Vasc Biol}, volume={40}, number={9}, pages={e260-e261}}"}}]}